Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Gross Margin (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Gross Margin readings, the most recent being 80.62% for Q4 2025.

  • On a quarterly basis, Gross Margin fell 13.0% to 80.62% in Q4 2025 year-over-year; TTM through Dec 2025 was 79.81%, a 56.0% decrease, with the full-year FY2025 number at 79.81%, down 56.0% from a year prior.
  • Gross Margin hit 80.62% in Q4 2025 for Treace Medical Concepts, up from 79.07% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 83.94% in Q4 2021 to a low of 79.07% in Q3 2025.
  • Median Gross Margin over the past 5 years was 80.82% (2021), compared with a mean of 81.03%.
  • Biggest five-year swings in Gross Margin: skyrocketed 785bps in 2021 and later plummeted -207bps in 2022.
  • Treace Medical Concepts' Gross Margin stood at 83.94% in 2021, then decreased by -2bps to 81.87% in 2022, then decreased by 0bps to 81.56% in 2023, then dropped by -1bps to 80.74% in 2024, then dropped by 0bps to 80.62% in 2025.
  • The last three reported values for Gross Margin were 80.62% (Q4 2025), 79.07% (Q3 2025), and 79.67% (Q2 2025) per Business Quant data.